Sign in
8-K

Current Report

Cadrenal Therapeutics, Inc. Filed Acc 0001213900-25-087461

Material agreement · Regulation FD disclosure · Other events

  • Item 1.01 Entry into a material definitive agreement
  • Item 7.01 Regulation FD disclosure
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading ea0257138-8k_cadrenal.htm…